MARIETTA, Ga., March 05, 2026 (GLOBE NEWSWIRE) -- MiMedx Group, Inc. (Nasdaq: MDXG) (“MIMEDX” or the “Company”) today announced the commercial launch of AMNIOFIX Thyroid Shields, a product line extension of the Company’s AMNIOFIX dehydrated human amnion/chorion membrane (DHACM) allografts.
Read more at globenewswire.comMIMEDX Expands Surgical Product Portfolio with the Launch of AMNIOFIX® Thyroid Shields
Provided By GlobeNewswire – Last update: